HQL — abrdn Life Sciences Investors
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital a...
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.
- Industry
- ETF
- Sector
- Financial Services
- Exchange
- NYSE
- First trade date
- 1992-05-01
The interactive platform loads with JavaScript. Research tools are for informational purposes.